| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5879514 | Journal of Pain and Symptom Management | 2013 | 10 Pages |
Abstract
Despite disease control and supportive care, intensively treated long-term myeloma survivors have significantly compromised HRQoL related to symptom burden. Systematic assessment is routinely indicated in advanced phase myeloma, even when disease activity is stable. Further studies should investigate the utility of interventional strategies and the relationship of cytokines with symptoms.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Elaine MD, MRCP, Christine PhD, Yousef MRCP, Diana M. PhD, Sam H. FRCP, John A. MD,